Gender differences in irritable bowel syndrome

Journal of Gender-Specific Medicine

Volumn 5, Issue 3, 2002, Pages 37-45

  Chial, Heather J ^a   Camilleri, Michael ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ABSENTEEISM; CLINICAL FEATURE; CONTROLLED STUDY; DEFECATION; DISABILITY; DISEASE ASSOCIATION; EPIDEMIOLOGY; FEMALE; GASTROENTEROLOGY; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HUMAN; IRRITABLE COLON; MALE; MORBIDITY; OUTPATIENT DEPARTMENT; PHYSIOLOGY; PRIMARY MEDICAL CARE; PSYCHOLOGY; REVIEW; SEX DIFFERENCE; TREATMENT OUTCOME; DAILY LIFE ACTIVITY; EATING DISORDER; FIBROMYALGIA; MENTAL STRESS; METABOLISM; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; UNITED STATES;

ACTIVITIES OF DAILY LIVING; COLONIC DISEASES, FUNCTIONAL; EATING DISORDERS; FEMALE; FIBROMYALGIA; FREE RADICAL SCAVENGERS; HUMAN; MALE; QUALITY OF LIFE; SEROTONIN; SEX FACTORS; STRESS, PSYCHOLOGICAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES; HUMANS;

SCAVENGER; SEROTONIN;

EID: 0035985451     PISSN: 15237036     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. The functional GI disorders and the Rome II process
2. Functional bowel disorders and functional abdominal pain
3. Irritable bowel syndrome: A technical review for practice guideline development
4. Organic and functional disorders in 2000 gastroenterology outpatients
5. Scope of the problem of functional digestive disorders
6. Irritable bowel syndrome defined by factor analysis: Gender and race comparisons
7. The incidence of clinically diagnosed irritable bowel syndrome in the community
8. Psychosocial aspects of the functional GI disorders
9. Motor function in irritable bowel syndrome
10. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms
11. Principles of applied neurogastroenterology: Physiology/motility-sensation
12. Basic and clinical aspects of visceral hyperalgesia
13. Enhanced perception of physiological intestinal motility in the irritable bowel syndrome
14. Altered rectal perception is a biological marker of patients with irritable bowel syndrome
15. Irritable bowel syndrome: Can the patient's response to colonoscopy help with diagnosis?
16. Fundamentals of neurogastroenterology
17. Prevalence of psychiatric disorders in patients with irritable bowel syndrome
18. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: Cohort study
19. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome
20. Functional bowel disorders and functional abdominal pain
21. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome
22. Diagnostic approach to the patient with irritable bowel syndrome
23. U.S. householder survey of functional GI disorders: Prevalence, sociodemography, and health impact
24. Irritable bowel syndrome
25. Irritable colon syndrome
26. Towards positive diagnosis of the irritable bowel
27. Gender differences in Manning criteria in the irritable bowel syndrome
28. Diagnostic value of the Manning criteria in irritable bowel syndrome
29. Gender differences in irritable bowel symptoms
30. Age, sex, and strain differences in the aversive threshold to grid shock in the rat
31. Female rats are more susceptible to the development of neuropathic pain using the partial sciatic nerve ligation (PSNL) model
32. Sex-related differences in the effects of morphine and stress on visceral pain
33. Gender differences in two forms of cold-water swim analgesia
34. Stress-induced opioid analgesia and activity in deer mice: Sex and population differences
35. Sex differences in the perception of noxious heat stimuli
36. Appraisal and response to pain may be a function of its bodily location
37. Chronic pain in a geographically defined general population: Studies of differences in age, gender, social class, and pain localization
38. Gender variations in clinical pain experience
39. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome
40. Pain from rectal distention in women with irritable bowel syndrome: Relationship to sexual abuse
41. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and non-painful rectal distention
42. Regional cerebral activity in normal and pathological perception of visceral pain
43. A longitudinal survey of self-reported bowel habits in the United States
44. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices
45. A case-control study to examine any association between idiopathic detrusor instability and GI tract disorder, and between irritable bowel syndrome and urinary tract disorder
46. High prevalence of irritable bowel syndrome in patients attending urological outpatient departments
47. Postpartum fecal incontinence is more common in women with irritable bowel syndrome
48. Bowel dysfunction in post-menopausal women
49. Pattern of GI and somatic symptoms across the menstrual cycle
50. Evidence for exacerbation of irritable bowel syndrome during menses
51. Do GI symptoms vary with the menstrual cycle?
52. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: A prevalence study
53. Does the menstrual cycle affect anorectal physiology?
54. Rectal and vaginal maximum tolerable volumes during menstrual cycle
55. The menstrual cycle affects rectal visceral sensitivity in patients with irritable bowel syndrome (IBS) but not healthy volunteers
56. Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome
57. The association of sexual abuse with pelvic pain complaints in a primary care population
58. Irritable bowel syndrome in women having diagnostic laparoscopy or hysterectomy: Relation to gynecologic features and outcome
59. Irritable bowel syndrome and chronic pelvic pain
60. The association between chronic pelvic pain, psychiatric diagnoses, and childhood sexual abuse
61. Irritable bowel-type symptoms in HMO examinees: Prevalence, demographics, and clinical correlates
62. Relation between hysterectomy and the irritable bowel: A prospective study
63. Bowel function and irritable bowel symptoms after hysterectomy and cholecystectomy: A population based study
64. Clinical management of intractable constipation
65. Epidemiology of colonic symptoms and the irritable bowel syndrome
66. Abdominal distention in female patients with irritable bowel syndrome: Exploration of possible mechanisms
67. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome
68. Psychological factors in the irritable bowel syndrome
69. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease
70. Psychosocial aspects of the functional GI disorders
71. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome?
72. The relationship between daily life stress and GI symptoms in women with irritable bowel syndrome
73. The relationship between psychological distress and GI symptoms in women with irritable bowel syndrome
74. Daily GI symptoms in women with and without a diagnosis of IBS
75. Sexual and physical abuse in women with functional or organic GI disorders
76. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease
77. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls: Results of a multicentre inquiry: French Club of Digestive Motility
78. Prevalence of sexual abuse among patients with functional disorders of the lower GI tract
79. Epidemiology of the eating disorders
80. Medical complications occurring in adolescents with anorexia nervosa
81. Functional GI disorders and eating disorders: Relevance of the association in clinical management
82. Fibromyalgia in the irritable bowel syndrome: Studies of prevalence and clinical implications
83. Primary fibromyalgia and the irritable bowel syndrome: Different expressions of a common pathogenetic process
84. Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of Oddi dysfunction, type III
85. Sleep disturbance influences GI symptoms in women with irritable bowel syndrome
86. Subjective and objective sleep quality in irritable bowel syndrome
87. Self-report and polysomnographic measures of sleep in women with irritable bowel syndrome
88. Sleep and gastric function in irritable bowel syndrome: Derailing the brain-gut axis
89. Differences between males and females in rates of serotonin synthesis in human brain
90. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist
91. Alosetron relieves pain and improves bowel function compared with mebeverine in female non-constipated irritable bowel syndrome patients
92. Alosetron slows colonic transit in patients with irritable bowel syndrome (IBS)
93. Effect of alosetron on responses to colonic distention in patients with irritable bowel syndrome
94. Tegaserod (HTF 919), a partial 5-HT4 receptor agonist, accelerates GI (GI) transit
95. Review article: Tegaserod
96. Tegaserod, a g-HT4 receptor partial agonist, relieves key symptoms of irritable bowel syndrome (IBS)
97. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
98. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome
99. Experience with anxiety and depression treatment studies: Implications for designing irritable bowel syndrome clinical trials